Hypermarcas (OTCMKTS:HYPMY) Short Interest Update

Hypermarcas (OTCMKTS:HYPMY) saw a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 50,686 shares, a growth of 9,217.3% from the January 15th total of 544 shares. Based on an average daily volume of 27,516 shares, the short-interest ratio is presently 1.8 days. Currently, 0.0% of the company’s shares are sold short. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 27,516 shares, the short-interest ratio is presently 1.8 days.

Hypermarcas Stock Up 0.3%

HYPMY stock opened at $4.48 on Thursday. Hypermarcas has a one year low of $3.10 and a one year high of $5.50. The firm has a market cap of $2.83 billion, a PE ratio of 19.46 and a beta of 0.71. The firm’s 50 day moving average price is $4.48 and its 200-day moving average price is $4.43. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27.

Hypermarcas (OTCMKTS:HYPMY) last posted its earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.The company had revenue of $408.83 million during the quarter.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.